Compare TEVA & KMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | KMB |
|---|---|---|
| Founded | 1901 | 1910 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5B | 32.5B |
| IPO Year | 1996 | 1994 |
| Metric | TEVA | KMB |
|---|---|---|
| Price | $40.88 | $99.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | $47.17 | ★ $114.80 |
| AVG Volume (30 Days) | ★ 5.3M | 3.9M |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 5.21% |
| EPS Growth | ★ 183.45 | N/A |
| EPS | N/A | ★ 3.03 |
| Revenue | N/A | ★ $16,447,000,000.00 |
| Revenue This Year | N/A | $0.85 |
| Revenue Next Year | $3.39 | $2.68 |
| P/E Ratio | ★ N/A | $32.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.83 | $92.42 |
| 52 Week High | $42.02 | $123.09 |
| Indicator | TEVA | KMB |
|---|---|---|
| Relative Strength Index (RSI) | 62.59 | 50.67 |
| Support Level | $30.41 | $97.28 |
| Resistance Level | N/A | $100.05 |
| Average True Range (ATR) | 1.06 | 1.79 |
| MACD | 0.07 | 0.67 |
| Stochastic Oscillator | 69.76 | 91.58 |
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.